Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Real-world comparison of BTKi monotherapy and fixed-duration BTKi–Venetoclax for first line treatment of chronic lymphocytic leukemia patients without TP53 mutations or IGHV rearrangement

Ansy Patel, Vedant Shah, Deevyashali Parekh, Osama Batayneh, Devashish Desai, Safa Elzein

Blood (2025) 146 (Supplement 1): 7435.

https://doi.org/10.1182/blood-2025-7435

Published: 2025

Journal Articles

Rising mortality attributed to agranulocytosis in myeloid leukemia among older adults in the United States : A time trend analysis

Ishani Shah, Pranay Vaghela, Vedant Shah, Sagar Patel, Michael Maroules

Blood (2025) 146 (Supplement 1): 8157.

https://doi.org/10.1182/blood-2025-8157

Published: 2025

Journal Articles

Trends in mortality from deep vein thrombosis and pulmonary embolism as multiple causes of death in u.S. adults aged ≥65 years (1999–2023): A CDC wonder analysis

Hakim Wazir, Amna Amjad, Khushbakht Shah, Nayanika Tummala, Shalin Rawal, Aleena Sharif, Anchit Chauhan, Minahil Zaheer, Abdul Majid, Shaheen Nawaz, Noora Inam, Vedant Shah, Bolivia Fernandes, Nirmit Patel, Love Kumar

Blood (2025) 146 (Supplement 1): 7993.

https://doi.org/10.1182/blood-2025-7993

Published: 2025

Journal Articles

Trends in mortality and comorbidity of multiple myeloma among u.S. adults with stroke: A CDC wonder-based analysis, 1999–2023

Muhammad Umar, Khushbakht Shah, Nayanika Tummala, Kashish Shah, Vedant Shah, Shalin Rawal, Amna Amjad, Saifullah Khan, Umaima Khan, Anchit Chauhan, Hakim Wazir, Yukthi Mudiam, Nandan Shah, Bolivia Fernandes, Love Kumar

Blood (2025) 146 (Supplement 1): 8147.

https://doi.org/10.1182/blood-2025-8147

Published: 2025

Journal Articles

Mortality trends in patients with co-occurring hematologic malignancies and heart failure in the United States population: A 25-year analysis using the CDC wonder database

Abdullah Bin Usman, Amna Amjad, Vedant Shah, Shalin Rawal, Nayanika Tummala, Sana Aijaz Ali, Hira Khan, Fizzah Ikram Ul Haq, Syed Mohamin Abbas Shah, Hakim Wazir, Nirmit Patel, Love Kumar, Amulya Bellamkonda

Blood (2025) 146 (Supplement 1): 6191.

https://doi.org/10.1182/blood-2025-6191

Published: 2025

Journal Articles

Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase-III Trials

Bolivia Crocete Aloysia Fernandes, Vedant Shah, Muhammad Ashar Ali, Abhi Shah, Makarand Madine, Mounika Gottumukkala, Sucharitha Pandeti, Safa Syed, Vinod Nookala

Blood (2024) 144 (Supplement 1): 6987.

https://doi.org/10.1182/blood-2024-209494

Published: 2024

Journal Articles

Evaluating Daratumumab Effectiveness in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Outcomes and Prognostic Indicators

Vedant Shah, Bolivia Crocete Aloysia Fernandes, Muhammad Ashar Ali, Abhi Shah, Kaushal Patel, Aditya Mansabdar, Arya Alla, Viraj Panchal, Pramil Cheriyath

Blood (2024) 144 (Supplement 1): 7071.

https://doi.org/10.1182/blood-2024-209400

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Real-world comparison of BTKi monotherapy and fixed-duration BTKi–Venetoclax for first line treatment of chronic lymphocytic leukemia patients without TP53 mutations or IGHV rearrangement

Rising mortality attributed to agranulocytosis in myeloid leukemia among older adults in the United States : A time trend analysis

Trends in mortality from deep vein thrombosis and pulmonary embolism as multiple causes of death in u.S. adults aged ≥65 years (1999–2023): A CDC wonder analysis

Trends in mortality and comorbidity of multiple myeloma among u.S. adults with stroke: A CDC wonder-based analysis, 1999–2023

Mortality trends in patients with co-occurring hematologic malignancies and heart failure in the United States population: A 25-year analysis using the CDC wonder database

Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase-III Trials

Evaluating Daratumumab Effectiveness in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Outcomes and Prognostic Indicators

Email alerts

ASH Publications

American Society of Hematology

Update search

Real-world comparison of BTKi monotherapy and fixed-duration BTKi–Venetoclax for first line treatment of chronic lymphocytic leukemia patients without TP53 mutations or IGHV rearrangement

Rising mortality attributed to agranulocytosis in myeloid leukemia among older adults in the United States : A time trend analysis

Trends in mortality from deep vein thrombosis and pulmonary embolism as multiple causes of death in u.S. adults aged ≥65 years (1999–2023): A CDC wonder analysis

Trends in mortality and comorbidity of multiple myeloma among u.S. adults with stroke: A CDC wonder-based analysis, 1999–2023

Mortality trends in patients with co-occurring hematologic malignancies and heart failure in the United States population: A 25-year analysis using the CDC wonder database

Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase-III Trials

Evaluating Daratumumab Effectiveness in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Outcomes and Prognostic Indicators

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only